Landmark Para - Medicals Exports Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-06-2024
- Paid Up Capital ₹ 0.10 M
as on 22-06-2024
- Company Age 19 Year, 22 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 22-06-2024
- Revenue %
(FY 2022)
- Profit -64.87%
(FY 2022)
- Ebitda -158.78%
(FY 2022)
- Net Worth -0.71%
(FY 2022)
- Total Assets 0.35%
(FY 2022)
About Landmark Para - Medicals Exports
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Kashmira Parekh and Rajesh Parekh serve as directors at the Company.
- CIN/LLPIN
U99999MH2005PTC157050
- Company No.
157050
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Landmark Para - Medicals Exports?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Parekh  | Director | 21-Oct-2005 | Current |
| Kashmira Parekh | Director | 26-Oct-2005 | Current |
Financial Performance and Corporate Structure Insights of Landmark Para - Medicals Exports.
Landmark Para - Medicals Exports Private Ltd, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 64.87% decrease in profit. The company's net worth dipped by a decrease of 0.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Landmark Para - Medicals Exports?
In 2019, Landmark Para - Medicals Exports had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Landmark Paramedical Supply & Sourcing L Lp
Active 8 years 4 monthsKashmira Parekh and Rajesh Parekh are mutual person
Amazon Health And Medical Llp
Active 6 years 8 monthsKashmira Parekh and Rajesh Parekh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Saraswat Co-Operative Bank Limited Creation Date: 05 Dec 2005 | ₹2.50 M | Open |
How Many Employees Work at Landmark Para - Medicals Exports?
Unlock and access historical data on people associated with Landmark Para - Medicals Exports, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Landmark Para - Medicals Exports, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Landmark Para - Medicals Exports's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
